Rohaan MW, Stahlie EHA, Franke V, Zijlker LP, et al. Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial. BMC Cancer 2022;22:851.
PMID: 35927710